News Agency
Men's Weekly

LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC)

  • Written by PR Newswire
  • Phase 2 study is underway and LB-P8 is the only live biotherapeutic product currently reported to be in clinical development for the treatment of PSC
  • FDA's Fast Track designation for LB-P8 underlines the urgent need for treatment options to fulfill the unmet medical needs of people affected by PSC

SEONGNAM, South Korea, March 29, 2024 /PRNe...

Read more: LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of...

How Headless CMS Enables Continuous Innovation Without Rebuilding Systems

Innovation is essential for staying competitive in today’s digital landscape, but many businesses struggle to innovate because their systems are not designed for change. Traditional content management systems often require significant redevelopment when new features, channels, or experiences are introduced... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion